共 34 条
[1]
Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells?
[J].
IMMUNOLOGY TODAY,
1998, 19 (01)
:2-5
[5]
Deeths MJ, 1999, EUR J IMMUNOL, V29, P45, DOI 10.1002/(SICI)1521-4141(199901)29:01<45::AID-IMMU45>3.0.CO
[6]
2-I
[7]
DUBEY C, 1995, J IMMUNOL, V155, P45
[8]
ENGERT A, 1990, CANCER RES, V50, P2929
[9]
The T-body approach: Potential for cancer immunotherapy
[J].
SPRINGER SEMINARS IN IMMUNOPATHOLOGY,
1996, 18 (02)
:199-209
[10]
SPECIFIC ACTIVATION AND TARGETING OF CYTOTOXIC LYMPHOCYTES THROUGH CHIMERIC SINGLE CHAINS CONSISTING OF ANTIBODY-BINDING DOMAINS AND THE GAMMA-SUBUNIT OR ZETA-SUBUNIT OF THE IMMUNOGLOBULIN AND T-CELL RECEPTORS
[J].
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,
1993, 90 (02)
:720-724